EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide

Vishnu Nagalapuram iD, Niveditha Popuri iD, Ryan D Nipp iD, Susanna V Ulahannan iD, Kelsey S Lau-Min iD

JCO Oncology Practice · 2025-09 · 21 (9) · 1247-1256

DOI: 10.1200/op-24-00872 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JCO Oncology Practice, 2025-09. Verfasst von Vishnu Nagalapuram und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, University of Oklahoma Stephenson Cancer Center, Oklahoma City, OK. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Global incidence of hepatocellular carcinoma (HCC) is rising along with its mortality burden, and more than half of the patients require systemic therapy for advanced disease. There is an ongoing epidemiologic shift in risk factors for HCC from hepatotropic virus–related liver disease to alcohol and metabolic dysfunction–associated steatotic liver disease. Although a diagnosis of HCC can be made with noninvasive radiologic criteria, tissue biopsy is gaining a role, at least within the realm of clinical trials. Despite advances in targeted therapies, the role of molecular testing in HCC remains unclear. Liver function continues to play a vital role in the management of HCC across all stages. With the approval of immune checkpoint inhibitors and tyrosine kinase inhibitors targeting tumor angiogenesis, the treatment landscape of advanced HCC has evolved considerably in the past decade, leading to improvements in patient outcomes. However, optimal sequencing of these agents is not well defined. There are several ongoing trials evaluating systemic therapies with novel mechanisms of action including adoptive cell therapy. This review aims to provide practicing oncologists with a comprehensive overview of recent developments in systemic therapy for the management of advanced HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansDisease Management

Autor:innen und Institutionen

  • Division of Hematology/Oncology, University of Oklahoma Stephenson Cancer Center, Oklahoma City, OK.
  • Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

ORCID-Profile: Vishnu Nagalapuram, Niveditha Popuri, Ryan D Nipp, Susanna V Ulahannan, Kelsey S Lau-Min

Förderung

  • NCI NIH HHS

Zitieren

APA

Nagalapuram, V., Popuri, N., Nipp, R. D., Ulahannan, S. V., & Lau-Min, K. S. (2025). Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide. JCO Oncology Practice, 21(9), 1247-1256. https://doi.org/10.1200/op-24-00872

Vancouver

Nagalapuram V, Popuri N, Nipp RD, Ulahannan SV, Lau-Min KS. Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide. JCO Oncology Practice. 2025;21(9):1247-1256. doi:10.1200/op-24-00872

BibTeX
@article{Nagalapuram2025,
  author = {Nagalapuram, Vishnu and Popuri, Niveditha and Nipp, Ryan D and Ulahannan, Susanna V and Lau-Min, Kelsey S},
  title = {Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide},
  journal = {JCO Oncology Practice},
  year = {2025},
  volume = {21},
  number = {9},
  pages = {1247--1256},
  doi = {10.1200/op-24-00872}
}
Kostenlos starten →